The percentage of patients with atrial fibrillation, currently treated with an anticoagulant, who have had a review in the preceding 12 months which included: assessment of stroke/VTE risk; assessment of bleeding risk; assessment of renal function, creatinine clearance, FBC and LFTs as appropriate for their anticoagulation therapy; any adverse effects related to anticoagulation; assessment of compliance; choice of anticoagulant
Single menu of indicators
The NICE indicator menu includes general practice and CCG level indicators by clinical area.
Use the filters to display indicators by type or subject - or filter by both, for more specific results.
Atrial fibrillation
The contractor establishes and maintains a register of patients with atrial fibrillation, including patients with ‘AF resolved’
The percentage of patients with one or more of the following conditions: CHD, atrial fibrillation, chronic heart failure, stroke or TIA, diabetes or dementia who have been screened for hazardous drinking using the FAST or AUDIT-C tool in the preceding 2 years.
The percentage of patients with one or more of the following conditions: CHD, atrial fibrillation, chronic heart failure, stroke or TIA, diabetes or dementia with a FAST score of 3 or more or AUDIT-C score of 5 or more in the preceding 2 years who have received brief intervention to help them reduce their alcohol related risk within 3 months of the score being recorded
Percentage of patients with atrial fibrillation and a last recorded CHA2DS2-VASc score of 2 or more who are currently prescribed a direct-acting oral anticoagulant (DOAC) if eligible, or a vitamin K antagonist if not eligible for a DOAC or a DOAC is declined or not indicated
The percentage of patients with atrial fibrillation in whom stroke risk has been assessed using the CHA2DS2-VASc score risk stratification scoring system in the preceding 12 months (excluding those patients with a previous CHADS2 or CHA2DS2-VASc score of 2 or more)
In those patients with atrial fibrillation with a record of a CHA2DS2-VASc score of 2 or more, the percentage of patients who are currently treated with anticoagulation drug therapy
Autism
The contractor establishes and maintains a register of all patients on the autistic spectrum
Bipolar, schizophrenia and other psychoses
Proportion of pregnant women who were asked about their mental health at their first booking appointment
Cancer
The proportion of invasive cases of cancer diagnosed via an emergency route
The proportion of new cases of cancer with stage at diagnosis recorded
The proportion of cancer cases detected at stage 1 or 2
Breast cancer mortality rates
The proportion of lung cancer cases for which a stage at diagnosis is recorded
The proportion of eligible people aged 60-74 years whose record shows a bowel screening test has been performed within the last 2.5 years
The proportion of women aged 50-70 years whose record shows a breast screening test has been performed within the last 3 years
Under 75 mortality rate from cancer (NHSOF)
Under 75 mortality rate from cancer (CCGOIS)
Mortality from breast cancer in females
Cancer stage at diagnosis
Cancers detected at stage 1 or 2
Record of lung cancer stage at decision to treat
People with urgent GP referral having first definitive treatment for cancer within 62 days
The proportion of patients eligible for cervical screening and aged 25 to 49 years at end of period reported whose notes record that an adequate cervical screening test has been performed in the previous 3.5 years
The proportion of patients eligible for cervical screening and aged 50 to 64 years at end of period reported whose notes record that an adequate cervical screening test has been performed in the previous 5.5 years